SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-026143
Filing Date
2021-11-10
Accepted
2021-11-10 16:05:37
Documents
60
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcda20210930_10q.htm   iXBRL 10-Q 772735
2 EXHIBIT 31.1 ex_303311.htm EX-31.1 11646
3 EXHIBIT 31.2 ex_303312.htm EX-31.2 11479
4 EXHIBIT 32.1 ex_303313.htm EX-32.1 4452
5 EXHIBIT 32.2 ex_303314.htm EX-32.2 4543
  Complete submission text file 0001437749-21-026143.txt   4002214

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bcda-20210930.xsd EX-101.SCH 44604
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcda-20210930_cal.xml EX-101.CAL 30966
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20210930_def.xml EX-101.DEF 259726
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20210930_lab.xml EX-101.LAB 255509
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20210930_pre.xml EX-101.PRE 289161
11 EXTRACTED XBRL INSTANCE DOCUMENT bcda20210930_10q_htm.xml XML 564425
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38999 | Film No.: 211396502
SIC: 2836 Biological Products, (No Diagnostic Substances)